Letter: Ozanimod and latent tuberculosis

Aliment Pharmacol Ther. 2023 Feb;57(3):353-354. doi: 10.1111/apt.17311.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Indans
  • Latent Tuberculosis* / diagnosis
  • Latent Tuberculosis* / drug therapy
  • Oxadiazoles

Substances

  • ozanimod
  • Indans
  • Oxadiazoles